

Shares in Ark Therapies fell back after the drug developer said it would consider approaches it has received following a recommendation that a further...


SDI swung into the black at the half-way stage, although the automated warehousing systems firm said the outlook remains "tough". There was a profit ...


Film distributor Entertainment One reports record takings for the UK and Canadian opening of The Twilight Saga: New Moon, the sequel to the 2008 box o...


Germ-killing product supplier Byotrol said it has seen a significant increase in orders and now expects results for the financial year to September 30...


Plethora Solutions has moved closer to global approval for its PSD502 premature ejaculation treatment for men after a final US phase 3 trial met all o...


Drug developer Plethora has sold the rights of its key PSD502 premature ejaculation product to Sciele Pharma to cut its debts and pay back venture cap...